Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.
Arima Genomics has raised $22.0M in total funding. The most recent round was Series C. The last funding was announced in June 2025.
Arima Genomics's investors include Illumina Ventures, Agilent Technologies, Berkeley Catalyst Fund (BCF), Vectr, TCA Venture Group.
Arima Genomics is headquartered in San Diego, United States.
Arima Genomics is a biotechnology company that develops solutions to drive genomics discovery.
Arima Genomics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arima Genomics — Funding & Investors." VCBacked, June 17, 2025, https://www.vcbacked.co/company/arima-genomics. Accessed September 30, 2026.
VCBacked. (2025). Arima Genomics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/arima-genomics
{{cite web |title=Arima Genomics — Funding & Investors |url=https://www.vcbacked.co/company/arima-genomics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated